BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yanbo Li, Caixia Guo, Zhicheng Wang, Pingsheng Gong, Zhiwei Sun, Shouliang Gong. Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cellsJournal of Huazhong University of Science and Technology [Medical Sciences] 2012; 32(2): 167 doi: 10.1007/s11596-012-0030-x
2
Yilin Zheng, Ziying Li, Haijun Chen, Yu Gao. Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapyEuropean Journal of Pharmaceutical Sciences 2020; 144: 105213 doi: 10.1016/j.ejps.2020.105213
3
Lin Lin Liu, Myles J. Smith, Bao Sheng Sun, Guan Jun Wang, H. Paul Redmond, Jiang Huai Wang. Combined IFN-γ–Endostatin Gene Therapy and Radiotherapy Attenuates Primary Breast Tumor Growth and Lung Metastases via Enhanced CTL and NK Cell Activation and Attenuated Tumor Angiogenesis in a Murine ModelAnnals of Surgical Oncology 2009; 16(5): 1403 doi: 10.1245/s10434-009-0343-6
4
CHANG-FENG LI, LI-BO CHEN, DAN-DAN LI, LEI YANG, BAO-GANG ZHANG, JING-PENG JIN, YING ZHANG, BIN ZHANG. Dual-sensitive HRE/Egr1 promoter regulates Smac overexpression and enhances radiation-induced A549 human lung adenocarcinoma cell death under hypoxiaMolecular Medicine Reports 2014; 10(2): 1108 doi: 10.3892/mmr.2014.2233
5
Yan-Ming Yang, Fang Fang, Xin Li, Lei Yu, Zhi-Cheng Wang. TRAIL overexpression co-regulated by Egr1 and HRE enhances radiosensitivity of hypoxic A549 cells depending on its apoptosis inducing roleOncology Reports 2017; 37(1): 533 doi: 10.3892/or.2016.5271